Sinovac Biotech Ltd
NASDAQ:SVA
Sinovac Biotech Ltd
NASDAQ:SVA
Price:
6.47
USD
Market Closed
Market Cap:
$644.7m
Balance Sheet
Balance Sheet Decomposition
Sinovac Biotech Ltd
Sinovac Biotech Ltd
Balance Sheet Decomposition is not available for
Sinovac Biotech Ltd
Sinovac Biotech Ltd
Balance Sheet
Sinovac Biotech Ltd
Sinovac Biotech Ltd
Currency: USD
| Dec-2002 | Dec-2003 | Dec-2004 | Dec-2005 | Dec-2006 | Dec-2007 | Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||||||
| Cash & Cash Equivalents |
0
|
1
|
3
|
7
|
9
|
17
|
33
|
75
|
102
|
104
|
91
|
107
|
91
|
64
|
62
|
114
|
158
|
153
|
1 041
|
11 609
|
4 278
|
1 270
|
|
| Cash Equivalents |
0
|
1
|
3
|
7
|
9
|
17
|
33
|
75
|
102
|
104
|
91
|
107
|
91
|
64
|
62
|
114
|
158
|
153
|
1 041
|
11 609
|
4 278
|
1 270
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
7
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
19
|
50
|
135
|
1 806
|
7 035
|
9 953
|
|
| Total Receivables |
0
|
1
|
5
|
7
|
10
|
17
|
20
|
26
|
26
|
18
|
23
|
32
|
41
|
39
|
50
|
66
|
77
|
114
|
253
|
952
|
609
|
451
|
|
| Accounts Receivables |
0
|
1
|
5
|
7
|
10
|
17
|
19
|
25
|
25
|
17
|
23
|
31
|
40
|
38
|
48
|
65
|
73
|
112
|
251
|
924
|
497
|
426
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
0
|
1
|
1
|
1
|
2
|
1
|
4
|
2
|
2
|
28
|
112
|
25
|
|
| Inventory |
1
|
1
|
0
|
1
|
2
|
4
|
6
|
10
|
15
|
8
|
11
|
14
|
19
|
19
|
14
|
20
|
25
|
28
|
106
|
376
|
181
|
140
|
|
| Other Current Assets |
0
|
0
|
0
|
1
|
0
|
2
|
2
|
1
|
4
|
2
|
1
|
4
|
4
|
7
|
4
|
4
|
5
|
5
|
25
|
172
|
23
|
17
|
|
| Total Current Assets |
2
|
4
|
8
|
16
|
22
|
39
|
61
|
119
|
147
|
132
|
126
|
157
|
155
|
128
|
131
|
204
|
284
|
350
|
1 560
|
14 915
|
12 126
|
11 831
|
|
| PP&E Net |
8
|
7
|
10
|
12
|
13
|
16
|
19
|
22
|
64
|
76
|
69
|
68
|
66
|
64
|
67
|
76
|
71
|
81
|
284
|
1 019
|
1 052
|
1 025
|
|
| PP&E Gross |
8
|
7
|
10
|
12
|
13
|
16
|
19
|
22
|
64
|
76
|
69
|
68
|
66
|
64
|
67
|
76
|
71
|
81
|
284
|
1 019
|
1 052
|
1 025
|
|
| Accumulated Depreciation |
0
|
1
|
2
|
2
|
3
|
5
|
6
|
8
|
11
|
16
|
20
|
27
|
32
|
37
|
38
|
46
|
49
|
51
|
58
|
140
|
265
|
477
|
|
| Intangible Assets |
2
|
1
|
1
|
2
|
2
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
10
|
9
|
|
| Note Receivable |
1
|
1
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
656
|
661
|
684
|
|
| Other Long-Term Assets |
0
|
0
|
1
|
1
|
1
|
1
|
2
|
3
|
2
|
7
|
12
|
15
|
17
|
11
|
14
|
19
|
15
|
22
|
55
|
157
|
265
|
109
|
|
| Total Assets |
13
N/A
|
14
+8%
|
22
+57%
|
31
+41%
|
37
+19%
|
57
+54%
|
83
+46%
|
145
+75%
|
214
+48%
|
216
+1%
|
209
-3%
|
241
+15%
|
239
-1%
|
203
-15%
|
211
+4%
|
299
+42%
|
370
+24%
|
452
+22%
|
1 901
+321%
|
16 748
+781%
|
14 115
-16%
|
13 658
-3%
|
|
| Liabilities | |||||||||||||||||||||||
| Accounts Payable |
3
|
2
|
3
|
1
|
1
|
1
|
1
|
3
|
4
|
8
|
2
|
6
|
3
|
2
|
2
|
7
|
6
|
6
|
31
|
59
|
20
|
17
|
|
| Accrued Liabilities |
0
|
0
|
0
|
1
|
2
|
4
|
4
|
7
|
7
|
5
|
8
|
9
|
9
|
10
|
9
|
33
|
27
|
32
|
122
|
537
|
250
|
258
|
|
| Short-Term Debt |
2
|
1
|
3
|
2
|
3
|
7
|
8
|
18
|
10
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
5
|
3
|
20
|
50
|
24
|
34
|
18
|
3
|
13
|
39
|
5
|
5
|
76
|
|
| Other Current Liabilities |
0
|
0
|
2
|
5
|
6
|
8
|
8
|
24
|
25
|
22
|
17
|
15
|
18
|
22
|
22
|
35
|
22
|
37
|
488
|
1 813
|
817
|
797
|
|
| Total Current Liabilities |
5
|
3
|
7
|
9
|
12
|
20
|
21
|
51
|
46
|
40
|
30
|
49
|
80
|
58
|
66
|
93
|
58
|
87
|
680
|
2 413
|
1 092
|
1 148
|
|
| Long-Term Debt |
0
|
1
|
0
|
3
|
4
|
1
|
2
|
0
|
10
|
17
|
31
|
32
|
2
|
1
|
9
|
15
|
4
|
1
|
8
|
17
|
12
|
178
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
324
|
242
|
264
|
|
| Minority Interest |
0
|
4
|
3
|
2
|
2
|
3
|
7
|
14
|
21
|
15
|
12
|
15
|
15
|
15
|
14
|
26
|
38
|
58
|
374
|
4 549
|
3 791
|
3 313
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
3
|
3
|
10
|
11
|
14
|
18
|
16
|
15
|
8
|
6
|
15
|
16
|
11
|
91
|
118
|
57
|
46
|
|
| Total Liabilities |
5
N/A
|
8
+60%
|
10
+25%
|
13
+30%
|
18
+38%
|
27
+50%
|
33
+22%
|
75
+127%
|
88
+17%
|
86
-2%
|
91
+6%
|
112
+23%
|
112
N/A
|
81
-28%
|
96
+19%
|
148
+54%
|
116
-22%
|
158
+36%
|
1 155
+631%
|
7 421
+543%
|
5 193
-30%
|
4 949
-5%
|
|
| Equity | |||||||||||||||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
1
|
1
|
6
|
11
|
12
|
4
|
4
|
24
|
15
|
15
|
0
|
7
|
6
|
3
|
3
|
29
|
50
|
90
|
195
|
8 656
|
8 764
|
8 658
|
|
| Additional Paid In Capital |
8
|
7
|
18
|
29
|
30
|
32
|
42
|
43
|
104
|
105
|
106
|
107
|
108
|
110
|
113
|
115
|
205
|
208
|
532
|
541
|
541
|
541
|
|
| Other Equity |
0
|
0
|
0
|
0
|
1
|
2
|
4
|
4
|
7
|
10
|
12
|
14
|
12
|
8
|
0
|
7
|
2
|
4
|
20
|
131
|
383
|
490
|
|
| Total Equity |
8
N/A
|
6
-25%
|
12
+100%
|
18
+50%
|
19
+6%
|
30
+58%
|
50
+67%
|
71
+42%
|
126
+77%
|
130
+3%
|
118
-9%
|
129
+9%
|
127
-2%
|
122
-4%
|
116
-5%
|
151
+30%
|
253
+68%
|
294
+16%
|
746
+154%
|
9 327
+1 150%
|
8 921
-4%
|
8 709
-2%
|
|
| Total Liabilities & Equity |
13
N/A
|
14
+8%
|
22
+57%
|
31
+41%
|
37
+19%
|
57
+54%
|
83
+46%
|
145
+75%
|
214
+48%
|
216
+1%
|
209
-3%
|
241
+15%
|
239
-1%
|
203
-15%
|
211
+4%
|
299
+42%
|
370
+24%
|
452
+22%
|
1 901
+321%
|
16 748
+781%
|
14 115
-16%
|
13 658
-3%
|
|
| Shares Outstanding | |||||||||||||||||||||||
| Common Shares Outstanding |
27
|
27
|
36
|
39
|
40
|
40
|
43
|
43
|
54
|
55
|
55
|
56
|
56
|
57
|
57
|
57
|
71
|
99
|
99
|
100
|
100
|
100
|
|
| Preferred Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
15
|
15
|
15
|
15
|
|
Switch to:
Switch to:
See Also
Discover More
